Morningside Venture Investments Ltd - Jan 17, 2023 Form 4 Insider Report for Kezar Life Sciences, Inc. (KZR)

Role
10%+ Owner
Signature
/s/ Frances Anne Elizabeth Richard, Director
Stock symbol
KZR
Transactions as of
Jan 17, 2023
Transactions value $
-$41,514
Form type
4
Date filed
1/19/2023, 03:12 PM
Previous filing
Jan 17, 2023
Next filing
Jan 25, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KZR Common Stock Sale -$41.5K -6.11K -0.1% $6.79 5.87M Jan 17, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.44 to $6.84, inclusive. The reporting person undertakes to provide to the staff of the Securities and Exchange Commission, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
F2 Frances Anne Elizabeth Richard, Jill Marie Franklin, Peter Stuart Allenby Edwards and Cheung Ka Ho, the directors of Morningside Venture Investments Limited ("MVIL"), share voting and dispositive control over the shares held by MVIL.